Tasimelteon: A selective and unique receptor binding profile

Neuropharmacology

Volumn 91, Issue , 2015, Pages 142-147

  Lavedan, Christian ^a   Forsberg, Mark ^a   Gentile, Anthony J ^b  

^a Vanda Pharmaceuticals Inc   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Circadian regulator; Circadian rhythm; Hetlioz ; Melatonin receptor; Non 24; Tasimelteon

Indexed keywords

ADENOSINE A1 RECEPTOR; ALDOSTERONE RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; AMPA RECEPTOR; ANDROGEN RECEPTOR; ANGIOTENSIN 1 RECEPTOR; APELIN RECEPTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; BRADYKININ B1 RECEPTOR; CALCITONIN RECEPTOR; CANNABINOID 1 RECEPTOR; GALANIN RECEPTOR 1; GLUCOCORTICOID RECEPTOR; HISTAMINE H1 RECEPTOR; INSULIN RECEPTOR; INTERLEUKIN 1 RECEPTOR; KAINIC ACID RECEPTOR; LEPTIN RECEPTOR; LEUKOTRIENE B4 RECEPTOR; MELANOCORTIN 1 RECEPTOR; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MOTILIN RECEPTOR; MUSCARINIC M1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; RECOMBINANT RECEPTOR; TASIMELTEON; UNINDEXED DRUG; BENZOFURAN DERIVATIVE; CYCLOPROPANE DERIVATIVE; MELATONIN RECEPTOR; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; AGONISTS; CHEMISTRY; HUMAN; METABOLISM;

BENZOFURANS; CYCLOPROPANES; HUMANS; PROTEIN BINDING; RECEPTORS, MELATONIN;

EID: 84921059225     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.12.004     Document Type: Article

References (51)

1. American Academy of Sleep Medicine ICSD-2-The International Classification of Sleep Disorders second ed. Diagnostic and Coding Manual 2005 American Academy of Sleep Medicine
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders fifth ed. 2013 390 (DSM-5)
3. M. Bourin, E. Mocaer, and R. Porsolt J. Psychiatry Neurosci. 29 2004 126 133
4. P. Boyce, and E. Barriball Aust. Fam. Physician 39 2010 307 310
5. C. Browning, I. Beresford, N. Fraser, and H. Giles Br. J Pharmacol. 129 2000 877 886
6. Y. Cheng, and W.H. Prusoff Biochem. Pharmacol. 22 1973 3099 3108
7. C.A. Czeisler, and J.J. Gooley Cold Spring Harb. Symp. Quant. Biol. 72 2007 579 597
8. S. Davis, D.K. Mirick, and R.G. Stevens J. Natl. Cancer Inst. 93 2001 1557 1562
9. A. DeLean, P.J. Munson, and D. Rodbard Am. J. Physiol. 235 1978 E97 E102
10. M.L. Dubocovich, and M. Markowska Endocrine 27 2005 101 110
11. M.L. Dubocovich, K. Yun, W.M. Al Ghoul, S. Benloucif, and M.I. Masana FASEB J. 12 1998 1211 1220
12. M.L. Dubocovich, R.L. Hudson, I.C. Sumaya, M.I. Masana, and E. Manna J. Pineal Res. 39 2005 113 120
13. A.E. Hunt, W.M. Al Ghoul, M.U. Gillette, and M.L. Dubocovich Am. J. Physiol. Cell Physiol. 280 2001 C110 C118
14. X. Jin Mol. Cell Biol. 23 2003 1054 1060
15. J.D. Johnston, S. Messager, P. Barrett, and D.G. Hazlerigg J. Neuroendocrinol. 15 2003 405 408
16. J.D. Johnston Proc. Natl. Acad. Sci. U.S.A 100 2003 2831 2835
17. B. Karlsson, A. Knutsson, and B. Lindahl Occup. Environ. Med. 58 2001 747 752
18. K. Kato Neuropharmacology 48 2005 301 310
19. D.M. Kemp, M. Ubeda, and J.F. Habener Mol. Cell Endocrinol. 191 2002 157 166
20. A. Knutsson Occup. Med (Lond) 53 2003 103 108
21. D.N. Krause, V.E. Barrios, and S.P. Duckles Eur. J. Pharmacol. 276 1995 207 213
22. C. Liu Neuron 19 1997 91 102
23. S.W. Lockley, J. Arendt, and D.J. Skene Dialogues Clin. Neurosci. 9 2007 301 314
24. S.W. Lockley, D.J. Dijk, O. Kosti, D.J. Skene, and J. Arendt J. Sleep. Res. 17 2008 207 216
25. S.W. Lockley Endoc. Rev. 34 2013 FP26-6
26. S.W. Lockley Endoc. Rev. 34 2013 SUN-137
27. S.W. Lockley Unpublished results 2014 (submitted for publication)
28. L.M. Luttrell Methods Mol. Biol. 332 2006 3 49
29. M.J. Millan J. Pharmacol. Exp. Ther. 306 2003 954 964
30. P. Monteleone, and M. Maj Eur. Neuropsychopharmacol. 18 2008 701 711
31. Y. Morikawa Scand. J. Work Environ. Health 31 2005 179 183
32. C.P. Nelson, and R.A. Challiss Biochem. Pharmacol 73 2007 737 751
33. R. Ochoa-Sanchez J. Neurosci. 31 2011 18439 18452
34. E. Peschke J. Pineal Res. 44 2008 26 40
35. M.A. Quera-Salva J. Sleep Res. P433 2014
36. S.M. Rajaratnam Lancet 373 2009 482 491
37. D.J. Ramsey, K.M. Ramsey, and D.G. Vavvas Semin. Ophthalmol. 28 2013 406 421
38. M. Ruger, and F.A. Scheer Rev. Endocr. Metab. Disord. 10 2009 245 260
39. R.L. Sack, and A.J. Lewy Sleep. Med. Rev. 5 2001 189 206
40. R.L. Sack Sleep 30 2007 1484 1501
41. E.S. Schernhammer J. Natl. Cancer Inst. 93 2001 1563 1568
42. E.S. Schernhammer J. Natl. Cancer Inst. 95 2003 825 828
43. D.J. Skene, S.W. Lockley, and J. Arendt Biol. Signals Recept. 8 1999 90 95
44. J.A. Sliman Sleep 37 2014 A167 A168
45. T.J. Swick 167th Annual Meeting, New York, NY 2014 American Psychiatric Association 419 420
46. R. Torres 167th Annual Meeting 2014 American Psychiatric Association New York, NY 483
47. F.W. Turek Int. Clin. Psychopharmacol. 22 Suppl. 2 2007 S1 S8
48. M. Uchiyama, and S.W. Lockley Sleep Med. Clin. 4 2009 195 211
49. D.B. Van, I.,F.A. Dijcks, P. Vanderheyden, G. Vauquelin, and M. Oortgiesen J. Pharmacol. Exp. Ther. 281 1997 1113 1119
50. M.V. Vyas BMJ 345 2012 e4800
51. B.T. Zhu J. Pharmacol. Toxicol. Methods 29 1993 85 91